For the readers interested in the stock health of Protagonist Therapeutics Inc. (PTGX). It is currently valued at $22.17. When the transactions were called off in the previous session, Stock hit the highs of $23.14, after setting-off with the price of $21.59. Company’s stock value dipped to $21.44 during the trading on the day. When the trading was stopped its value was $21.86.
Recently in News on November 11, 2020, Protagonist Therapeutics to Participate in the Jefferies Virtual 2020 London Healthcare Conference. Protagonist Therapeutics, Inc. (NASDAQ:PTGX) today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the upcoming Jefferies Virtual 2020 London Healthcare Conference. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Protagonist Therapeutics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $24.02 on 11/12/20, with the lowest value was $5.30 for the same time period, recorded on 03/18/20.
Protagonist Therapeutics Inc. (PTGX) full year performance was 108.36%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Protagonist Therapeutics Inc. shares are logging -7.70% during the 52-week period from high price, and 395.97% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $4.47 and $24.02.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1312268 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Protagonist Therapeutics Inc. (PTGX) recorded performance in the market was 214.47%, having the revenues showcasing 11.13% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 866.18M, as it employees total of 76 workers.
The Analysts eye on Protagonist Therapeutics Inc. (PTGX)
During the last month, 0 analysts gave the Protagonist Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 19.50, with a change in the price was noted +4.78. In a similar fashion, Protagonist Therapeutics Inc. posted a movement of +27.49% for the period of last 100 days, recording 334,654 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for PTGX is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical rundown of Protagonist Therapeutics Inc. (PTGX)
Raw Stochastic average of Protagonist Therapeutics Inc. in the period of last 50 days is set at 71.88%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 71.88%. In the last 20 days, the company’s Stochastic %K was 69.25% and its Stochastic %D was recorded 70.77%.
Considering, the past performance of Protagonist Therapeutics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 214.47%. Additionally, trading for the stock in the period of the last six months notably improved by 38.56%, alongside a boost of 108.36% for the period of the last 12 months. The shares increased approximately by -1.12% in the 7-day charts and went down by 10.13% in the period of the last 30 days. Common stock shares were driven by 11.13% during last recorded quarter.